Figure 1
Figure 1. Dose-exposure evaluation. Steady-state (day 28) idelalisib plasma exposures by idelalisib dosing regimen (N = 50). AUC0-6, area under the concentration-time curve over 6 hours; Cmax, maximum concentration; Ctrough, trough concentration; SEM, standard error of the mean.

Dose-exposure evaluation. Steady-state (day 28) idelalisib plasma exposures by idelalisib dosing regimen (N = 50). AUC0-6, area under the concentration-time curve over 6 hours; Cmax, maximum concentration; Ctrough, trough concentration; SEM, standard error of the mean.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal